Described herein are pharmaceutical packaging units which reduce oxidative degradation of morphine, hydromorphone, promethazine together with other oxygen-sensitive medicines, such systems which include a syringe using an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with pretty minimal permeability to oxygen and